Peng, Y., Wang, Y., Tang, N., Sun, D., Lan, Y., Yu, Z., . . . Lv, C. (2018). Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway. BMC.
Chicago Style (17th ed.) CitationPeng, Yulin, et al. Andrographolide Inhibits Breast Cancer Through Suppressing COX-2 Expression and Angiogenesis via Inactivation of P300 Signaling and VEGF Pathway. BMC, 2018.
MLA (8th ed.) CitationPeng, Yulin, et al. Andrographolide Inhibits Breast Cancer Through Suppressing COX-2 Expression and Angiogenesis via Inactivation of P300 Signaling and VEGF Pathway. BMC, 2018.
Warning: These citations may not always be 100% accurate.